1. Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer. (December 2016) Authors: Ylstra, B.; Cordes, M.; Biesma, H.D.; Verheul, H.M.; Neerincx, M.; Koopman, M.; Punt, C.J.; Meijer, G.A.; Murphy, V.; Barat, A.; Betge, J.; Ebert, M.; Gaiser, T.; Fender, B.; Klinger, R.; Das, S.; Smeets, D.; Lambrechts, D.; Byrne, A.T.; Van Grieken, N.C.T. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MON-PP095: Muscle Wasting of ≥10% During Chemotherapy is Independently Associated with Survival. (September 2015) Authors: Blauwhoff-Buskermolen, S.; Versteeg, K.S.; de van der Schueren, M.A.; den Braver, N.R.; Berkhof, H.J.; Langius, J.A.; Verheul, H.M. Journal: Clinical nutrition Issue: Volume 34(2015)Supplement 1 Page Start: S163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OR017: The Assessment of Anorexia in Patients with Cancer: Cut-Off Values for the FAACT-A/CS and the Vas for Appetite. (September 2015) Authors: Blauwhoff-Buskermolen, S.; Ruijgrok, C.; Ostelo, R.W.; de Vet, H.C.; Verheul, H.M.; de van der Schueren, M.A.; Langius, J.A. Journal: Clinical nutrition Issue: Volume 34(2015)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treatment and survival of locally advanced pancreatic cancer: A prospective multicenter cohort. (2020) Authors: Walma, M.S.; Brada, L.J.; Patuleia, S.I.; Rombouts, S.J.; Schouten, T.J.; Verweij, M.E.; De Hingh, I.H.; Creemers, G.J.; Nederend, J.; Stommel, M.W.; Radema, S.A.; Hermans, J.J.; Van Dam, R.; De Vos-Geelen, J.M.; Van der Leij, C.; Liem, M.S.; Mekenkamp, L.J.; Stassen, E.J.; Los, M.; Bollen, T.L. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗